UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 238

Sortiert nach

HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects

Nature medicine, 2010-04, Vol.16 (4), p.460

2010

Volltextzugriff (PDF)

Phase I clinical trial of an intranodally administered mRNA-based therapeutic vaccine against HIV-1 infection

AIDS (London), 2018-11, Vol.32 (17), p.2533-2545

2018

Volltextzugriff (PDF)

New challenges in therapeutic vaccines against HIV infection

Expert review of vaccines, 2017-06, Vol.16 (6), p.587-600

2017

Volltextzugriff (PDF)

Mortality, Causes of Death and Associated Factors Relate to a Large HIV Population-Based Cohort

PloS one, 2015-12, Vol.10 (12), p.e0145701

2015

Volltextzugriff (PDF)

A Therapeutic Dendritic Cell-Based Vaccine for HIV-1 Infection

The Journal of infectious diseases, 2011-02, Vol.203 (4), p.473-478

2011

Volltextzugriff (PDF)

Mitochondrial Effects of HIV Infection on the Peripheral Blood Mononuclear Cells of HIV-Infected Patients Who Were Never Treated with Antiretrovirals

Clinical infectious diseases, 2004-09, Vol.39 (5), p.710-716

2004

Volltextzugriff (PDF)

Combination of Biological Screening in a Cellular Model of Viral Latency and Virtual Screening Identifies Novel Compounds That Reactivate HIV-1

Journal of Virology, 2012-04, Vol.86 (7), p.3795-3808

2012

Volltextzugriff (PDF)

Backbones versus core agents in initial ART regimens: one game, two players

Journal of antimicrobial chemotherapy, 2016-04, Vol.71 (4), p.856-861

2016

Volltextzugriff (PDF)

Intensification of a raltegravir-based regimen with maraviroc in early HIV-1 infection

AIDS (London), 2014-01, Vol.28 (3), p.325-334

2014

Volltextzugriff (PDF)

A dendritic cell-based vaccine elicits T cell responses associated with control of HIV-1 replication

Science translational medicine, 2013-01, Vol.5 (166), p.166ra2

2013

Volltextzugriff (PDF)

Effective Treatment of Lymphogranuloma venereum Proctitis With Azithromycin

Clinical infectious diseases, 2021-08, Vol.73 (4), p.614-620

2021

Volltextzugriff (PDF)

Association of microbial translocation biomarkers with clinical outcome in controllers HIV-infected patients

AIDS (London), 2015-03, Vol.29 (6), p.675-681

2015

Volltextzugriff (PDF)

Treatment intensification with raltegravir in subjects with sustained HIV―1 viraemia suppression: a randomized 48―week study

Antiviral therapy, 2012-01, Vol.17 (2), p.355-364

2012

Volltextzugriff (PDF)

Impact of long-term antiretroviral therapy interruption and resumption on viral reservoir in HIV-1 infected patients

AIDS (London), 2017-08, Vol.31 (13), p.1895-1897

2017

Volltextzugriff (PDF)

Engineering new mycobacterial vaccine design for HIV-TB pediatric vaccine vectored by lysine auxotroph of BCG

Molecular therapy. Methods & clinical development, 2014-01, Vol.1 (C), p.14017-14017, Article 14017

2014

Volltextzugriff (PDF)

Imbalance in mitochondrial dynamics and apoptosis in pregnancies among HIV-infected women on HAART with obstetric complications

Journal of antimicrobial chemotherapy, 2017-09, Vol.72 (9), p.2578-2586

2017

Volltextzugriff (PDF)

Rate and predictors of non-AIDS events in a cohort of HIV-infected patients with a CD4 T cell count above 500 cells/mm

AIDS research and human retroviruses, 2013-08, Vol.29 (8), p.1161

2013

Volltextzugriff (PDF)

A Classifier to Predict Viral Control After Antiretroviral Treatment Interruption in Chronic HIV-1-Infected Patients

Journal of acquired immune deficiency syndromes (1999), 2020-04, Vol.83 (5), p.479

2020

Volltextzugriff (PDF)

A randomized clinical trial comparing ritonavir-boosted lopinavir versus raltegravir each with tenofovir plus emtricitabine for post-exposure prophylaxis for HIV infection

Journal of antimicrobial chemotherapy, 2016-07, Vol.71 (7), p.1987-1993

2016

Volltextzugriff (PDF)

Clinical implications of fixed-dose coformulations of antiretrovirals on the outcome of HIV-1 therapy

AIDS (London), 2011-09, Vol.25 (14), p.1683-1690

2011

Volltextzugriff (PDF)

A randomized clinical trial comparing ritonavir-boosted lopinavir versus maraviroc each with tenofovir plus emtricitabine for post-exposure prophylaxis for HIV infection

Journal of antimicrobial chemotherapy, 2016-07, Vol.71 (7), p.1982-1986

2016

Volltextzugriff (PDF)

HIV-1 Reservoir Dynamics after Vaccination and Antiretroviral Therapy Interruption Are Associated with Dendritic Cell Vaccine-Induced T Cell Responses

Journal of virology, 2015-09, Vol.89 (18), p.9189-9199

2015

Volltextzugriff (PDF)

Involvement of the LPS-LPB-CD14-MD2-TLR4 inflammation pathway in HIV-1/HAART-associated lipodystrophy syndrome (HALS)

Journal of antimicrobial chemotherapy, 2014-06, Vol.69 (6), p.1653-1659

2014

Volltextzugriff (PDF)

Cost–effectiveness of initial antiretroviral treatment administered as single vs. multiple tablet regimens with the same or different components

Enfermedades infecciosas y microbiologia clinica, 2018-01, Vol.36 (1), p.16-20

2018

Volltextzugriff (PDF)

Dynamics of CD8 T-cell activation after discontinuation of HIV treatment intensification

Journal of acquired immune deficiency syndromes (1999), 2013-06, Vol.63 (2), p.152

2013

Volltextzugriff (PDF)

1 – 25 von 238

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(229)
Mit Volltextzugriff
(185)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(186)
Science & Technology
(179)
Life Sciences & Biomedicine
(173)
Infectious Diseases
(147)
Adult
(136)
Female
(136)
Male
(136)
Hiv Infections - Drug Therapy
(101)
Biological And Medical Sciences
(90)
Medical Sciences
(87)
Human Immunodeficiency Virus
(84)
Immunology
(84)
Middle Aged
(83)
Hiv
(82)
Microbiology
(76)
Virology
(75)
Aids/hiv
(65)
Viral Diseases
(56)
Human Viral Diseases
(55)
Viral Diseases Of The Lymphoid Tissue And The Blood. Aids
(49)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects

Phase I clinical trial of an intranodally administered mRNA-based therapeutic vaccine against HIV-1 infection

New challenges in therapeutic vaccines against HIV infection

Mortality, Causes of Death and Associated Factors Relate to a Large HIV Population-Based Cohort

A Therapeutic Dendritic Cell-Based Vaccine for HIV-1 Infection

Mitochondrial Effects of HIV Infection on the Peripheral Blood Mononuclear Cells of HIV-Infected Patients Who Were Never Treated with Antiretrovirals

Combination of Biological Screening in a Cellular Model of Viral Latency and Virtual Screening Identifies Novel Compounds That Reactivate HIV-1

Backbones versus core agents in initial ART regimens: one game, two players

Intensification of a raltegravir-based regimen with maraviroc in early HIV-1 infection

A dendritic cell-based vaccine elicits T cell responses associated with control of HIV-1 replication

Effective Treatment of Lymphogranuloma venereum Proctitis With Azithromycin

Association of microbial translocation biomarkers with clinical outcome in controllers HIV-infected patients

Treatment intensification with raltegravir in subjects with sustained HIV―1 viraemia suppression: a randomized 48―week study

Impact of long-term antiretroviral therapy interruption and resumption on viral reservoir in HIV-1 infected patients

Engineering new mycobacterial vaccine design for HIV-TB pediatric vaccine vectored by lysine auxotroph of BCG

Imbalance in mitochondrial dynamics and apoptosis in pregnancies among HIV-infected women on HAART with obstetric complications

Rate and predictors of non-AIDS events in a cohort of HIV-infected patients with a CD4 T cell count above 500 cells/mm

A Classifier to Predict Viral Control After Antiretroviral Treatment Interruption in Chronic HIV-1-Infected Patients

A randomized clinical trial comparing ritonavir-boosted lopinavir versus raltegravir each with tenofovir plus emtricitabine for post-exposure prophylaxis for HIV infection

Clinical implications of fixed-dose coformulations of antiretrovirals on the outcome of HIV-1 therapy

A randomized clinical trial comparing ritonavir-boosted lopinavir versus maraviroc each with tenofovir plus emtricitabine for post-exposure prophylaxis for HIV infection

HIV-1 Reservoir Dynamics after Vaccination and Antiretroviral Therapy Interruption Are Associated with Dendritic Cell Vaccine-Induced T Cell Responses

Involvement of the LPS-LPB-CD14-MD2-TLR4 inflammation pathway in HIV-1/HAART-associated lipodystrophy syndrome (HALS)

Cost–effectiveness of initial antiretroviral treatment administered as single vs. multiple tablet regimens with the same or different components

Dynamics of CD8 T-cell activation after discontinuation of HIV treatment intensification

Suchergebnisse filtern